| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2018/02/09 | 23 : 13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/07 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 04 : 22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 02 : 20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 02 : 20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 2017/11/01 | 02 : 20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |